Hypoglycemic Agents: all 3,927 studies that test it
Page 37 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 DiabetesCompletedNCT00336674Phase 2
- A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus PatientsStatus unknownNCT00336310Phase 4
- Lantus Effect on Myocardial Glucose Metabolism in T2CompletedNCT00335465Phase 4
- Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers DiseaseTerminatedNCT00334568Phase 2
- Open Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideCompletedNCT00334503Phase 3
- Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideCompletedNCT00334399Phase 3
- AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide AloneCompletedNCT00333723Phase 4
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00333151Phase 3
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00331851Phase 3
- Safety and Efficacy of Inhaled Insulin in Type 2 DiabetesTerminatedNCT00331604Phase 3
- Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCompletedNCT00331487Phase 3
- Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On InsulinCompletedNCT00329225Phase 4
- Effect of Pioglitazone on Ambulatory Blood PressureCompletedNCT00328393Phase 3
- Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot StudyTerminatedNCT00325910Phase 3
- Long-Term Safety Study of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00325429Phase 3
- To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea MonotherapyCompletedNCT00325117Phase 3
- LANCGMS - Lantus Continuous Glucose Monitoring SubcutaneousCompletedNCT00322075Phase 4
- Efficacy of Metformin in Lean Women With Polycystic Ovary SyndromeStatus unknownNCT00319293Not applicable
- Efficacy and Safety of Nateglinide Treatment in Renal Transplant RecipientsCompletedNCT00319189Phase 4
- Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 DiabetesCompletedNCT00318786Phase 3
- The Effect Of AVANDIA On The Late Asthmatic ResponseCompletedNCT00318630Phase 1
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00318422Phase 3
- Efficacy of Metformin in PCOS: Metabolic and Hormonal FactorsStatus unknownNCT00317928Not applicable
- The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic SyndromeCompletedNCT00314561Phase 4
- The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar DisorderCompletedNCT00314314Phase 3
- SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1CompletedNCT00313937Phase 4
- The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting InsulinsCompletedNCT00313742Phase 4
- A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes MellitusCompletedNCT00313183Phase 2
- Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.CompletedNCT00313001Phase 3
- Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 DiabetesCompletedNCT00312156Phase 3
- A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetesCompletedNCT00312130Phase 3
- Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 DiabetesCompletedNCT00312104Phase 3
- Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT00311818Phase 4
- Insulin Glulisine in Healthy Lean and Obese SubjectsCompletedNCT00311077Phase 1
- Insulin Glulisine in Type 2 Diabetes MellitusCompletedNCT00310297Phase 1
- Treatment With Local PPARgamma Ligand in Distal Ulcerative ColitisStatus unknownNCT00309660Phase 1/2
- Metabolic and Renal Effects of Rosiglitazone in Kidney TransplantCompletedNCT00309309Phase 2
- Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes MellitusCompletedNCT00308373Not applicable
- An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.CompletedNCT00307619Phase 3
- Pioglitazone in Impaired Glucose ToleranceWithdrawnNCT00306826Phase 4
- Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.CompletedNCT00306696Phase 4
- Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 DiabetesCompletedNCT00306644Phase 4
- Rosiglitazone and Exercise in Patients With Type 2 Diabetes MellitusCompletedNCT00306176Phase 4
- Study of Niacin and Rosiglitazone in Dysmetabolic DyslipidemiaCompletedNCT00304993Phase 4
- Metformin in Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT00303537Phase 2/3
- A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild HyperglycemiaCompletedNCT00300287Phase 3
- Insulin Glulisine in Type 1 Diabetes MellitusCompletedNCT00297583Phase 1
- BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-CompletedNCT00297063Phase 3
- Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's DiseaseTerminatedNCT00296959Phase 2
- Continuous Subcutaneous Infusion of Pramlintide and InsulinCompletedNCT00291772Phase 4
- Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes MellitusCompletedNCT00290979Phase 3
- Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes MellitusCompletedNCT00290927Phase 3
- Glulisine Pre- and PostmealCompletedNCT00290043Phase 1
- Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.WithdrawnNCT00287456Not applicable
- A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose DispositionTerminatedNCT00287066Phase 3
- Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in ChildrenTerminatedNCT00286988Phase 4
- Integrating the Genetic and Metabolic Faces of ObesityCompletedNCT00285844Phase 1
- Effect of RosiglitazoneCompletedNCT00285142Not applicable
- Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 DiabetesCompletedNCT00283751Phase 3
- Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or RosiglitazoneTerminatedNCT00282945Not applicable
- Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 DiabetesCompletedNCT00282451Phase 4
- Safety and Efficacy Study of Topiramate to Aid in Smoking CessationCompletedNCT00280839Phase 3
- Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00280046Phase 3
- Life Style Modifications Prevents Type 2 Diabetes in Asian IndiansCompletedNCT00279240Phase 1
- Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideCompletedNCT00279045Phase 3
- Role of Pioglitazone in Preventing DiabetesCompletedNCT00276497Phase 1
- Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty LiverTerminatedNCT00274495Phase 4
- Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesCompletedNCT00274274Phase 4
- Insulin Glargine in Type 1 Diabetes MellitusCompletedNCT00272090Phase 3
- ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.CompletedNCT00272064Phase 3
- OPAL - Insulin Glulisine, Diabetes MellitusCompletedNCT00272012Phase 3
- Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic PatientsCompletedNCT00271284Phase 3
- Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or InsulinCompletedNCT00269061Phase 1
- Insulin Glargine in Type 2 DiabetesCompletedNCT00268645Phase 4
- Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyActive, not recruitingNCT00268476Phase 2/3
- Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 DiabetesTerminatedNCT00267683Phase 3
- A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of EpilepsyCompletedNCT00266604Phase 4
- A Study of the Efficacy and Safety of Topiramate Treatment in Patients With EpilepsyCompletedNCT00266591Phase 3
- Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational DiabetesWithdrawnNCT00265746Phase 4
- Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 DiabetesCompletedNCT00264901Phase 4
- ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin SensitivityTerminatedNCT00263965Phase 2
- An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With TriptansCompletedNCT00261469Phase 2
- GALLANT 14 Tesaglitazar vs. Metformin and FenofibrateTerminatedNCT00261352Phase 3
- A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 DiabetesCompletedNCT00260156Phase 3
- Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?CompletedNCT00259168Phase 4
- Insulin Glargine During and After the Period of Fasting in RamadanCompletedNCT00258804Phase 4
- GALLANT 4 Tesaglitazar vs. GlibenclamideTerminatedNCT00255541Phase 3
- Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.Status unknownNCT00254085Phase 4
- A Study of the Effectiveness and Safety of Topiramate for the Prevention of MigraineCompletedNCT00253175Phase 3
- GALLANT 8 Tesaglitazar Add-on to MetforminTerminatedNCT00251953Phase 3
- Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1Status unknownNCT00249691Phase 3
- Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT00247117Not applicable
- Efficacy of Topiramate for Weight Loss in Subjects With Metabolic SyndromeSuspendedNCT00243984Phase 3
- Rosiglitazone Effects on Cognition for Adults in Later LifeStatus unknownNCT00242593Phase 2
- Pilot Test of ACTOS in Multiple Sclerosis: Safety and TolerabilityCompletedNCT00242177Phase 1
- AVANDAMET Versus Metformin For Type 2 Diabetes MellitusCompletedNCT00241605Phase 4
- A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar DisorderCompletedNCT00240721Phase 3
- Prevention of Corticosteroid-induced Glucose IntoleranceStatus unknownNCT00240604Phase 3
- A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 DiabetesCompletedNCT00240253Phase 4
- A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00238498Phase 2